The U.K. company presented findings that its 360 e-Lung technology could potentially speed up the diagnosis of progressive pulmonary fibrosis by nearly two years in more than half of the patients ...

A recent study validates that combining genetic and clinical data can predict the risk for pulmonary fibrosis in patients ...

Individuals in close proximity to care for interstitial lung disease (ILD) did not have significantly improved outcomes than those at a greater distance, based on data from more than 1600 individuals ...

Early diagnosis and treatment in IPF and PPF are vital, as fibrosis is irreversible and current therapies only slow progression. Current IPF treatments, pirfenidone and nintedanib, have significant ...

Under current screening guidelines, almost two-thirds of Americans with lung cancer would not have qualified for required ...

Study in Lancet Digital Health represents the largest real-world evaluation of stroke AI imaging, encompassing data from more ...

A new study shows that the U.S. Preventive Services Task Force screening criteria for lung cancer exclude at-risk patients.

We present the case of an 82-year-old woman with progressive dyspnea, hoarseness, and dysphagia due to a large substernal ...

At first, it just seemed like a post-pandemic hangover: scattered patients drifting into Yorkshire clinics with damaged lungs. Then a pattern emerged that began to hint at a New COVID-linked syndrome ...

In a study of nearly 1,000 consecutive patients treated for lung cancer at Northwestern Medicine, researchers discovered only 35% would have qualified for screening, according to the U.S. Preventive ...